secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0000950170-24-017881
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla awards 2023 cash bonuses and RSUs to executives; approves 2024 bonus plan
--------------------------------------------------------------------------------

- CEO Jay Short receives $419,491 cash bonus for 2023; CFO Waldron $184,718; CMO Sievers $184,338; CAO Vasquez $115,800.
- Time-based RSU grants: 417,000 to Short, 106,000 to Waldron, 122,000 to Sievers, 70,000 to Vasquez; vest over 4 years.
- Compensation Committee approved 2024 Corporate Bonus Plan; targets: CEO 60%, other officers 40% of base salary.
- 2024 bonus heavily weighted: 30% clinical milestones, 20% strategic partnerships, 20% financing, 10% R&D, 10% financial/people, 10% brand.
- Vasquez promoted to CAO effective Jan 1, 2024; target bonus increased to 40% from 35%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000095017024017881/0000950170-24-017881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000095017024017881/bcab-20240215.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-017881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer